Kaveri Pohlman
Stock Analyst at Clear Street
(0.73)
# 4,006
Out of 5,182 analysts
33
Total ratings
22.58%
Success rate
-15.93%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kaveri Pohlman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVMN Evommune | Initiates: Buy | $53 | $23.72 | +123.44% | 1 | Mar 18, 2026 | |
| MLTX MoonLake Immunotherapeutics | Maintains: Buy | $45 → $70 | $17.36 | +303.23% | 1 | Mar 11, 2026 | |
| ERAS Erasca | Maintains: Buy | $11 → $20 | $17.81 | +12.30% | 1 | Mar 6, 2026 | |
| JANX Janux Therapeutics | Downgrades: Hold | $32 → $12 | $14.84 | -19.14% | 3 | Jan 20, 2026 | |
| PALI Palisade Bio | Initiates: Buy | $12 | $1.89 | +534.92% | 1 | Dec 30, 2025 | |
| GPCR Structure Therapeutics | Maintains: Buy | $61 → $99 | $53.48 | +85.12% | 1 | Dec 9, 2025 | |
| PVLA Palvella Therapeutics | Initiates: Buy | $200 | $123.46 | +62.00% | 1 | Dec 5, 2025 | |
| JBIO Jade Biosciences | Initiates: Buy | $25 | $15.49 | +61.39% | 1 | Nov 25, 2025 | |
| TRVI Trevi Therapeutics | Maintains: Buy | $11 → $21 | $11.94 | +75.88% | 1 | Nov 14, 2025 | |
| ZURA Zura Bio | Initiates: Buy | $18 | $6.03 | +198.51% | 1 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $29 | $5.32 | +445.11% | 1 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 | $53.31 | -13.71% | 1 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $24.89 | +28.57% | 1 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.07 | - | 4 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $47 | $27.50 | +70.91% | 3 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $30 | $14.43 | +107.90% | 2 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $56 → $38 | $12.81 | +196.64% | 1 | Apr 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $5 | $4.41 | +13.38% | 2 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8 | $1.48 | +440.54% | 1 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $43.88 | -38.47% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $22.96 | +204.88% | 1 | Aug 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $6.42 | +86.92% | 1 | Aug 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $8 | $4.56 | +75.44% | 2 | Jul 7, 2022 |
Evommune
Mar 18, 2026
Initiates: Buy
Price Target: $53
Current: $23.72
Upside: +123.44%
MoonLake Immunotherapeutics
Mar 11, 2026
Maintains: Buy
Price Target: $45 → $70
Current: $17.36
Upside: +303.23%
Erasca
Mar 6, 2026
Maintains: Buy
Price Target: $11 → $20
Current: $17.81
Upside: +12.30%
Janux Therapeutics
Jan 20, 2026
Downgrades: Hold
Price Target: $32 → $12
Current: $14.84
Upside: -19.14%
Palisade Bio
Dec 30, 2025
Initiates: Buy
Price Target: $12
Current: $1.89
Upside: +534.92%
Structure Therapeutics
Dec 9, 2025
Maintains: Buy
Price Target: $61 → $99
Current: $53.48
Upside: +85.12%
Palvella Therapeutics
Dec 5, 2025
Initiates: Buy
Price Target: $200
Current: $123.46
Upside: +62.00%
Jade Biosciences
Nov 25, 2025
Initiates: Buy
Price Target: $25
Current: $15.49
Upside: +61.39%
Trevi Therapeutics
Nov 14, 2025
Maintains: Buy
Price Target: $11 → $21
Current: $11.94
Upside: +75.88%
Zura Bio
Nov 13, 2025
Initiates: Buy
Price Target: $18
Current: $6.03
Upside: +198.51%
Oct 22, 2025
Initiates: Buy
Price Target: $29
Current: $5.32
Upside: +445.11%
Sep 17, 2025
Maintains: Buy
Price Target: $46
Current: $53.31
Upside: -13.71%
Jun 25, 2025
Initiates: Buy
Price Target: $32
Current: $24.89
Upside: +28.57%
Aug 1, 2024
Downgrades: Neutral
Price Target: n/a
Current: $3.07
Upside: -
Jun 27, 2024
Maintains: Buy
Price Target: $46 → $47
Current: $27.50
Upside: +70.91%
Apr 17, 2024
Maintains: Buy
Price Target: $20 → $30
Current: $14.43
Upside: +107.90%
Apr 16, 2024
Maintains: Buy
Price Target: $56 → $38
Current: $12.81
Upside: +196.64%
Mar 26, 2024
Upgrades: Buy
Price Target: $5
Current: $4.41
Upside: +13.38%
Feb 9, 2024
Initiates: Buy
Price Target: $8
Current: $1.48
Upside: +440.54%
Dec 19, 2023
Initiates: Buy
Price Target: $27
Current: $43.88
Upside: -38.47%
Aug 23, 2023
Reiterates: Buy
Price Target: $70
Current: $22.96
Upside: +204.88%
Aug 31, 2022
Initiates: Buy
Price Target: $12
Current: $6.42
Upside: +86.92%
Jul 7, 2022
Maintains: Buy
Price Target: $16 → $8
Current: $4.56
Upside: +75.44%